Monday, August 21, 2023 10:15:44 PM
It's evident that your comprehension of business intricacies might need a bit of refining. Being an OTC-listed company during its development phase is a common strategy for emerging businesses. It allows them the flexibility to focus on their innovation without the immediate pressures of stringent reporting and compliance measures that often come with larger exchanges. This should be a "duh"-type of understanding which isn't prevalent in your negatively-themed KBLB postings.
Now, let's delve into your fascination with "FACT-FILLED" accounts of forward-looking PR'd statements. Because in the world of innovation and development, every plan unfolds precisely as laid out on a timeline, right? Oh, how simple and linear you seem to perceive the path to success. The reality is that innovation is riddled with uncertainties, pivots, and the occasional hiccups. Another "duh" statement that should be easy to notice for those understanding development. What separates the understanding investor from the amateur is the recognition that development involves risks and adjustments.
It's quite ironic that you attempt to point fingers at the company and its CEO for being on the OTC, as if that's a mark of incompetence. In fact, it's a conscious strategic choice that countless successful startups have made to foster growth without the immediate scrutiny and demands of a larger exchange. "Duh," again. Well, should be.
So, in your quest to cling to the notion of "failures," you conveniently disregard the bigger picture and the calculated steps taken by the company. If you're looking for a "shining star," perhaps start by reevaluating your own approach to understanding the dynamics of businesses in development, rather than naively assuming you have it all figured out. "Duh!"
DROP-IN AND GO KBLB! HOLDING THE GOLDEN!!!
Recent KBLB News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 06/10/2024 08:30:30 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/04/2024 04:15:03 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM